Curis is a therapeutic drug development company. The Company’s technology focus is
on regulatory pathways that control repair and regeneration. Curis product development
involves using proteins or small molecules to modulate these pathways, for
example, increasing the pathway signals when they are insufficient or decreasing them
when they excessive. Curis has successfully used this technology and product development
strategy to produce several promising drug product candidates in the fields of
kidney disease, neurological disorders, cancer, and alopecia (hair loss).
URL: www.curis.com Phone: 617-503-6500.
Daniel R. Passeri, President and Chief Executive Officer, spoke with
Wall Street Reporter Magazine on August 13, 2003.

Click for complete article:
article pdf